Glass House Brands (GLAS) Current Leases (2020 - 2026)
Glass House Brands (GLAS) posted quarterly Current Leases of $1.3 million for Q1 2026, down 11.96% year-over-year from $1.5 million in Q1 2025, and up 16.76% quarter-over-quarter from $1.1 million in Q4 2025.
Glass House Brands (GLAS) Current Leases (2020 - 2026) Analysis & Trends
Glass House Brands (GLAS) has reported Current Leases for 7 consecutive years, with $1.3 million the latest figure, recorded in Q1 2026.
- In Q1 2026, Current Leases fell 11.96% year-over-year to $1.3 million; the TTM figure through Mar 2026 stood at $1.3 million (down 11.96% YoY), while the FY2025 annual figure was $1.1 million, up 25.53% from the prior year.
- Current Leases climbed to $1.3 million in Q1 2026 per GLAS's latest filing, from $1.1 million in the prior quarter.
- Across five years, Current Leases topped out at $1.6 million in Q3 2024 and bottomed at $66790.0 in Q4 2022.
- Historically, Current Leases has averaged $1.0 million across 5 years, with a median of $1.1 million in 2023.
- Annual changes were most pronounced in 2022 — Current Leases sank 75.19% — and 2023, when it jumped 479.43%.
- Glass House Brands' Current Leases stood at $66790.0 in 2022, then surged by 479.43% to $387000.0 in 2023, then jumped by 129.72% to $889000.0 in 2024, then advanced by 25.53% to $1.1 million in 2025, then advanced by 16.76% to $1.3 million in 2026.
- Business Quant data shows GLAS's Current Leases at $1.3 million in Q1 2026, $1.1 million in Q4 2025, and $1.1 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Leases (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.89 Bn | 42.93 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.01 Bn | 39.35 Bn | 2.15 Bn | - |
| 3 | Zoetis | 31.52 Bn | 29.84 Bn | 1.05 Bn | - |
| 4 | Takeda Pharmaceutical | 28.61 Bn | 22.81 Bn | 5.10 Bn | - |
| 5 | United Therapeutics | 22.17 Bn | 19.51 Bn | 683.80 Mn | - |
| 6 | Viatris | 18.73 Bn | 17.85 Bn | 1.46 Bn | - |
| 7 | Neurocrine Biosciences | 15.51 Bn | 15.12 Bn | 935.80 Mn | - |
| 8 | Elanco Animal Health | 11.75 Bn | 11.22 Bn | 798.00 Mn | - |
| 9 | Dr Reddys Laboratories | 10.12 Bn | 9.96 Bn | - | - |
| 10 | Glass House Brands | 830.21 Mn | 811.66 Mn | 15.77 Mn | 325,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 1.30 Mn |
| Dec 31, 2025 | 1.12 Mn |
| Sep 30, 2025 | 1.08 Mn |
| Jun 30, 2025 | 1.12 Mn |
| Mar 31, 2025 | 1.48 Mn |
| Dec 31, 2024 | 889,000.00 |
| Sep 30, 2024 | 1.62 Mn |
| Jun 30, 2024 | 1.27 Mn |
| Mar 31, 2024 | 1.36 Mn |
| Dec 31, 2023 | 387,000.00 |
| Sep 30, 2023 | 1.52 Mn |
| Jun 30, 2023 | 1.17 Mn |
| Mar 31, 2023 | 1.12 Mn |
| Dec 31, 2022 | 66,790.00 |
| Sep 30, 2022 | 1.19 Mn |
| Jun 30, 2022 | 561,127.00 |
| Mar 31, 2022 | 286,457.00 |
| Dec 31, 2021 | 269,154.00 |
| Sep 30, 2021 | 219,114.00 |
| Mar 31, 2021 | 185,508.00 |